Genvor Partners with B2i Digital to Expand Investor Reach for AI-Driven Agricultural Solutions
TL;DR
Genvor's AI-accelerated peptide platform offers agricultural companies a competitive edge by reducing crop losses through sustainable biological solutions that outperform traditional methods.
Genvor's BioCypher Algorithm leverages 50,000 designed peptides and 30 years of research to systematically develop targeted solutions that reduce aflatoxin contamination by 76-98% in crops.
Genvor's sustainable agricultural solutions help create a better tomorrow by reducing global crop losses and providing safer, biological alternatives to chemical pesticides for food production.
Genvor's AI platform designs peptides that can reduce fungal toxins in corn by up to 98%, using computational biology to revolutionize crop protection.
Found this article helpful?
Share it with your network and spread the knowledge!
Genvor Inc. has partnered with B2i Digital to expand investor awareness of its artificial intelligence-driven agricultural biotechnology platform. The collaboration comes at a pivotal moment for Genvor as the company advances its licensing-first business model and expands partnerships with major agricultural companies.
The partnership will leverage B2i Digital's multi-channel digital marketing engine and targeted outreach campaigns to connect Genvor with investors interested in sustainable agriculture solutions. David Shapiro, CEO of B2i Digital, expressed enthusiasm for the collaboration, noting Genvor's leadership and their clear articulation of the growing demand for biological solutions in agriculture. B2i Digital's platform can be accessed at https://b2idigital.com.
Genvor's technology addresses a critical global challenge: the estimated $220 billion in annual crop losses caused by plant pathogens worldwide. The company's proprietary BioCypher Algorithm leverages more than 50,000 designed peptides and over 30 years of foundational research to create targeted solutions for major agricultural problems. This platform has demonstrated significant efficacy, including 76% to 98% reductions in total aflatoxin contamination in transgenic corn seeds across pathogens such as Aspergillus flavus and Fusarium species.
Chad Pawlak, CEO of Genvor, emphasized the timing of this partnership, citing the company's accelerated momentum with recently issued patents, active partnership discussions, and a growing development pipeline. The company maintains a growing intellectual property portfolio that includes two issued U.S. patents and one pending application covering 24 proprietary peptides. In November 2025, Genvor announced the issuance of U.S. Patent No. 12,458,684 for transgenic corn expressing antifungal peptide AGM182, co-assigned to Genvor and the United States Department of Agriculture.
Genvor's development pipeline spans multiple major crops including corn, citrus, rice, soybeans, cotton, flax, and potato, with applications across both foliar spray solutions and seed traits. The company is currently engaged with major agricultural companies on joint venture evaluations and commercialization discussions. More information about Genvor's technology and business model is available at https://www.genvor.com.
This partnership represents a significant development in the agricultural technology sector, where sustainable solutions are increasingly critical for global food security. The collaboration between Genvor and B2i Digital highlights the growing importance of investor awareness in scaling innovative agricultural technologies that can address substantial economic losses while promoting environmental sustainability. As climate change and population growth continue to pressure global food systems, technologies like Genvor's AI-accelerated peptide platform could play a vital role in ensuring stable food production while reducing environmental impact.
Curated from NewMediaWire
